Livforsakringsbolaget Skandia’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-17,400
Closed -$1.64M 660
2020
Q4
$1.64M Hold
17,400
0.14% 139
2020
Q3
$1.51M Hold
17,400
0.16% 122
2020
Q2
$1.4M Hold
17,400
0.16% 127
2020
Q1
$1.14M Hold
17,400
0.16% 125
2019
Q4
$1.9M Hold
17,400
0.23% 113
2019
Q3
$1.59M Hold
17,400
0.19% 124
2019
Q2
$1.7M Hold
17,400
0.21% 116
2019
Q1
$1.75M Hold
17,400
0.23% 108
2018
Q4
$1.42M Hold
17,400
0.21% 112
2018
Q3
$1.72M Sell
17,400
-3,400
-16% -$359K 0.2% 130
2018
Q2
$2.25M Hold
20,800
0.2% 128
2018
Q1
$2.17M Hold
20,800
0.21% 128
2017
Q4
$2.44M Buy
+20,800
New +$2.15M 0.23% 118

Other funds holding CRI

Livforsakringsbolaget Skandia's CRI Position: Q1 2021 in Review

Livforsakringsbolaget Skandia sold out of Carter's (CRI) in Q1 2021, closing a stake of 17,400 shares — an estimated $1.64M sold.

Livforsakringsbolaget Skandia first reported a position in CRI in Q4 2017 and held it in 13 quarters. The position peaked at $2.44M in Q4 2017. 300 funds tracked by Wall St. Rank hold CRI as of Q1 2021.

  • Livforsakringsbolaget Skandia reported no remaining Carter's position as of Q1 2021 after selling out during the quarter.
  • Livforsakringsbolaget Skandia sold 17,400 Carter's shares in Q1 2021, an estimated $1.64M.
  • Livforsakringsbolaget Skandia first reported a position in Carter's in Q4 2017 and held it in 13 quarters.
  • Livforsakringsbolaget Skandia's Carter's position peaked at $2.44M in Q4 2017.
  • 300 funds tracked by Wall St. Rank held Carter's as of Q1 2021.

Based on Livforsakringsbolaget Skandia's 13F filing for Q1 2021, filed 7 May 2021.